JFS Wealth Advisors’s Abiomed Inc ABMD Stock Holding History

JFS Wealth Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16	Closed	-$4K	–	2010
2022 Q3	$4K	Buy	16 +10	+167%	+$2.7K	﹤0.01%	1123
2022 Q2	$1K	Sell	6 -4	-40%	-$1.08K	﹤0.01%	1704
2022 Q1	$3K	Buy	10 +6	+150%	+$1.85K	﹤0.01%	1350
2021 Q4	$1K	Buy	+4	New	+$1.35K	﹤0.01%	1666

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JFS Wealth Advisors's ABMD Position: Q4 2022 in Review

JFS Wealth Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 16 shares — an estimated $4K sold.

JFS Wealth Advisors first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $4K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

JFS Wealth Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
JFS Wealth Advisors sold 16 Abiomed Inc shares in Q4 2022, an estimated $4K.
JFS Wealth Advisors first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
JFS Wealth Advisors's Abiomed Inc position peaked at $4K in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on JFS Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.